149 related articles for article (PubMed ID: 26971421)
1. Impact of multiparametric magnetic resonance imaging on risk group assessment of patients with prostate cancer addressed to external beam radiation therapy.
Pullini S; Signor MA; Pancot M; Zuiani C; Bazzocchi M; Fongione S; Girometti R
Eur J Radiol; 2016 Apr; 85(4):764-70. PubMed ID: 26971421
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric magnetic resonance imaging versus Partin tables and the Memorial Sloan-Kettering cancer center nomogram in risk stratification of patients with prostate cancer referred to external beam radiation therapy.
Girometti R; Pancot M; Signor MA; Urbani M; Balestreri L; Zuiani C
Radiol Med; 2018 Oct; 123(10):778-787. PubMed ID: 29752647
[TBL] [Abstract][Full Text] [Related]
3. Can multiparametric MRI replace Roach equations in staging prostate cancer before external beam radiation therapy?
Girometti R; Signor MA; Pancot M; Cereser L; Zuiani C
Eur J Radiol; 2016 Dec; 85(12):2231-2237. PubMed ID: 27842672
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
[TBL] [Abstract][Full Text] [Related]
5. Can 3-Tesla pelvic phased-array multiparametric MRI avoid unnecessary repeat prostate biopsy in patients with PSA < 10 ng/mL?
Pepe P; Garufi A; Priolo G; Pennisi M
Clin Genitourin Cancer; 2015 Feb; 13(1):e27-30. PubMed ID: 25081324
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric MRI for prostate cancer detection: Preliminary results on quantitative analysis of dynamic contrast enhanced imaging, diffusion-weighted imaging and spectroscopy imaging.
Fusco R; Sansone M; Petrillo M; Setola SV; Granata V; Botti G; Perdonà S; Borzillo V; Muto P; Petrillo A
Magn Reson Imaging; 2016 Sep; 34(7):839-45. PubMed ID: 27071309
[TBL] [Abstract][Full Text] [Related]
7. Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience.
Panje C; Panje T; Putora PM; Kim SK; Haile S; Aebersold DM; Plasswilm L
Radiat Oncol; 2015 Feb; 10():47. PubMed ID: 25880635
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
9. Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China.
Zhang Q; Wang W; Zhang B; Shi J; Fu Y; Li D; Guo S; Zhang S; Huang H; Jiang X; Zhou W; Guo H
Int Urol Nephrol; 2017 Mar; 49(3):439-448. PubMed ID: 28005230
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment multiparametric MRI is independently associated with biochemical outcome in men treated with radiation therapy for prostate cancer.
Kauffmann G; Arif F; Patel P; Oto A; Liauw SL
Urol Oncol; 2018 Oct; 36(10):471.e11-471.e18. PubMed ID: 30122344
[TBL] [Abstract][Full Text] [Related]
11. A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection.
Hendriks RJ; van der Leest MMG; Dijkstra S; Barentsz JO; Van Criekinge W; Hulsbergen-van de Kaa CA; Schalken JA; Mulders PFA; van Oort IM
Prostate; 2017 Oct; 77(14):1401-1407. PubMed ID: 28853167
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric (mp) MRI of prostate cancer.
Kumar V; Bora GS; Kumar R; Jagannathan NR
Prog Nucl Magn Reson Spectrosc; 2018 Apr; 105():23-40. PubMed ID: 29548365
[TBL] [Abstract][Full Text] [Related]
13. Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy.
Jambor I; Kähkönen E; Taimen P; Merisaari H; Saunavaara J; Alanen K; Obsitnik B; Minn H; Lehotska V; Aronen HJ
J Magn Reson Imaging; 2015 May; 41(5):1394-404. PubMed ID: 24956412
[TBL] [Abstract][Full Text] [Related]
14. Correlation of quantitative diffusion-weighted and dynamic contrast-enhanced MRI parameters with prognostic factors in prostate cancer.
Chung MP; Margolis D; Mesko S; Wang J; Kupelian P; Kamrava M
J Med Imaging Radiat Oncol; 2014 Oct; 58(5):588-94. PubMed ID: 25196228
[TBL] [Abstract][Full Text] [Related]
15. Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with endorectal coil.
Zattoni F; Kawashima A; Morlacco A; Davis BJ; Nehra AK; Mynderse LA; Froemming AT; Jeffrey Karnes R
Pract Radiat Oncol; 2017; 7(1):42-49. PubMed ID: 27527896
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA.
De Visschere P; Lumen N; Ost P; Decaestecker K; Pattyn E; Villeirs G
Clin Radiol; 2017 Jan; 72(1):23-32. PubMed ID: 27726850
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric magnetic resonance imaging for prostate cancer: A review and update for urologists.
Yoo S; Kim JK; Jeong IG
Korean J Urol; 2015 Jul; 56(7):487-97. PubMed ID: 26175867
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment Multiparametric Magnetic Resonance Imaging Findings Are More Accurate Independent Predictors of Outcome Than Clinical Variables in Localized Prostate Cancer.
Gomez-Iturriaga A; Casquero F; Pijoan JI; Crook J; Urresola A; Ezquerro A; Villeirs GM; Bossi A; Cacicedo J; Buchser D; Bilbao P
Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1172-1178. PubMed ID: 29861199
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric MR Imaging for Detection and Locoregional Staging of Prostate Cancer.
Bittencourt LK; de Hollanda ES; de Oliveira RV
Top Magn Reson Imaging; 2016 Jun; 25(3):109-17. PubMed ID: 27187165
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer.
An JY; Sidana A; Choyke PL; Wood BJ; Pinto PA; Türkbey İB
Balkan Med J; 2017 Sep; 34(5):388-396. PubMed ID: 28990929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
